HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Uchiba Selected Research

1- myristoyl- 2- (12- ((5- dimethylamino- 1- naphthalenesulfonyl)amino)dodecanoyl)- sn- glycero- 3- phosphocholine

11/2000Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation.
8/2000Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation.
6/2000Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Uchiba Research Topics

Disease

6Leukopenia
09/2001 - 03/2000
3Ischemia
06/2003 - 06/2000
3Spinal Cord Injuries (Spinal Cord Injury)
05/2001 - 03/2000
3Vascular System Injuries
11/2000 - 01/2000
2Hemorrhage
01/2017 - 11/2000
2Disseminated Intravascular Coagulation
01/2017 - 11/2000
2Sepsis (Septicemia)
03/2008 - 04/2000
2Hypotension (Low Blood Pressure)
12/2001 - 09/2001
2Septic Shock (Toxic Shock Syndrome)
12/2001 - 09/2001
1Hemophilia A (Haemophilia)
01/2017
1Pain (Aches)
01/2017
1Shock
12/2001
1Liver Diseases (Liver Disease)
11/2000
1Aortic Aneurysm (Aneurysm, Aortic)
11/2000
1Infections
11/2000
1Neoplasms (Cancer)
11/2000
1Hematologic Neoplasms (Hematological Malignancy)
11/2000
1Spinal Cord Ischemia
08/2000
1AIDS-Related Complex (ARC)
06/2000
1Inflammation (Inflammations)
04/2000
1Wounds and Injuries (Trauma)
03/2000
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2000
1Pulmonary Edema
01/2000

Drug/Important Bio-Agent (IBA)

7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2008 - 03/2000
5Protein CIBA
09/2001 - 03/2000
4LipopolysaccharidesIBA
12/2001 - 01/2000
4AnticoagulantsIBA
09/2001 - 04/2000
31- myristoyl- 2- (12- ((5- dimethylamino- 1- naphthalenesulfonyl)amino)dodecanoyl)- sn- glycero- 3- phosphocholineIBA
11/2000 - 06/2000
3Factor Xa (Coagulation Factor Xa)IBA
11/2000 - 06/2000
2Factor VIIa (Activated Factor VII)IBA
01/2017 - 11/2000
2Dacarbazine (DIC)FDA LinkGeneric
01/2017 - 11/2000
2lipoprotein-associated coagulation inhibitor (TFPI)IBA
12/2001 - 11/2000
2Messenger RNA (mRNA)IBA
05/2001 - 03/2000
2Monoclonal AntibodiesIBA
05/2001 - 06/2000
2P-SelectinIBA
05/2001 - 06/2000
2salicylhydroxamic acid (SHAM)IBA
05/2001 - 08/2000
2KetonesIBA
11/2000 - 06/2000
2Mechlorethamine (Nitrogen Mustard)FDA Link
08/2000 - 06/2000
2fluorophosphate (sodium monofluorophosphate)FDA Link
08/2000 - 06/2000
1Factor X (Stuart Factor)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1PotassiumIBA
01/2017
1MC710IBA
01/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2001
1Nitric Oxide Synthase (NO Synthase)IBA
12/2001
1pimagedine (aminoguanidine)IBA
09/2001
1MethylprednisoloneFDA LinkGeneric
05/2001
1(2S)- 2- (4- (((3S)- 1- acetimidoyl- 3- pyrrolidinyl)oxy)phenyl)- 3- (7- amidino- 2- naphtyl)propanoic acidIBA
11/2000
1recombinant FVIIa (rFVIIa)FDA Link
11/2000
1Antifibrinolytic Agents (Antifibrinolytics)IBA
11/2000
1FibrinolysinFDA Link
11/2000
1Ranitidine (Zantac)FDA LinkGeneric
08/2000
1Peroxidase (Myeloperoxidase)IBA
08/2000
1Hematoxylin (Haematoxylon)IBA
08/2000
1ThrombinFDA Link
08/2000
1Eosine Yellowish-(YS) (Eosin)IBA
08/2000
1CytokinesIBA
08/2000
1Interleukin-8 (Interleukin 8)IBA
08/2000
1glutamyl-glycyl-arginyl-chloromethyl ketoneIBA
08/2000
1triphenyltetrazoliumIBA
08/2000
1Heparin (Liquaemin)FDA LinkGeneric
06/2000
1sivelestatIBA
06/2000
1Secretory Proteinase Inhibitory ProteinsIBA
06/2000
1eglin proteinase inhibitors (eglin C)IBA
06/2000
1AntithrombinsIBA
04/2000
1Therapeutic UsesIBA
03/2000
1ThrombomodulinIBA
03/2000
1cepharanthineIBA
01/2000

Therapy/Procedure

3Intravenous Administration
05/2001 - 01/2000
1Catheters
08/2000